Roz N - Search Results

1

Chronic clozapine, but not haloperidol, treatment affects rat brain vesicular monoamine transporter 2.

Rehavi M, Roz N, Weizman A. Rehavi M, et al. Among authors: roz n. Eur Neuropsychopharmacol. 2002 Jun;12(3):261-8. doi: 10.1016/s0924-977x(02)00021-4. Eur Neuropsychopharmacol. 2002. PMID: 12007678

2

Inhibition of vesicular uptake of monoamines by hyperforin.

Roz N, Mazur Y, Hirshfeld A, Rehavi M. Roz N, et al. Life Sci. 2002 Sep 27;71(19):2227-37. doi: 10.1016/s0024-3205(02)01995-1. Life Sci. 2002. PMID: 12215370

3

Decreased platelet vesicular monoamine transporter density in children and adolescents with attention deficit/hyperactivity disorder.

Toren P, Rehavi M, Luski A, Roz N, Laor N, Lask M, Weizman A. Toren P, et al. Among authors: roz n. Eur Neuropsychopharmacol. 2005 Mar;15(2):159-62. doi: 10.1016/j.euroneuro.2004.07.002. Eur Neuropsychopharmacol. 2005. PMID: 15695060

4

Altered affinity of the platelet vesicular monoamine transporter 2 to dihydrotetrabenazine in children with major depression.

Zalsman G, Rehavi M, Roz N, Laor N, Weizman A, Toren P. Zalsman G, et al. Among authors: roz n. J Neural Transm (Vienna). 2011 Sep;118(9):1383-7. doi: 10.1007/s00702-011-0643-4. Epub 2011 Apr 12. J Neural Transm (Vienna). 2011. PMID: 21484276 Clinical Trial.

5

Platelet vesicular monoamine transporter 2 density in the disruptive behavior disorders.

Zalsman G, Aslanov-Farbstein D, Rehavi M, Roz N, Vermeiren R, Laor N, Weizman A, Toren P. Zalsman G, et al. Among authors: roz n. J Child Adolesc Psychopharmacol. 2011 Aug;21(4):341-4. doi: 10.1089/cap.2010.0148. J Child Adolesc Psychopharmacol. 2011. PMID: 21851191

6

Hyperforin inhibits vesicular uptake of monoamines by dissipating pH gradient across synaptic vesicle membrane.

Roz N, Rehavi M. Roz N, et al. Life Sci. 2003 Jun 13;73(4):461-70. doi: 10.1016/s0024-3205(03)00295-9. Life Sci. 2003. PMID: 12759140

7

Hyperforin depletes synaptic vesicles content and induces compartmental redistribution of nerve ending monoamines.

Roz N, Rehavi M. Roz N, et al. Life Sci. 2004 Oct 22;75(23):2841-50. doi: 10.1016/j.lfs.2004.08.004. Life Sci. 2004. PMID: 15464835

8

N-methyl-citalopram: A quaternary selective serotonin reuptake inhibitor.

Bismuth-Evenzal Y, Roz N, Gurwitz D, Rehavi M. Bismuth-Evenzal Y, et al. Among authors: roz n. Biochem Pharmacol. 2010 Nov 15;80(10):1546-52. doi: 10.1016/j.bcp.2010.07.035. Epub 2010 Aug 7. Biochem Pharmacol. 2010. PMID: 20696140

9

Promiscuous gating modifiers target the voltage sensor of K(v)7.2, TRPV1, and H(v)1 cation channels.

Kornilov P, Peretz A, Lee Y, Son K, Lee JH, Refaeli B, Roz N, Rehavi M, Choi S, Attali B. Kornilov P, et al. Among authors: roz n. FASEB J. 2014 Jun;28(6):2591-602. doi: 10.1096/fj.14-250647. Epub 2014 Mar 5. FASEB J. 2014. PMID: 24599966

10

The involvement of sodium ions in the positive inotropic effect of naloxone.

Levin G, Gafni M, Roz N, Sarne Y. Levin G, et al. Among authors: roz n. Gen Pharmacol. 1993 Mar;24(2):423-8. doi: 10.1016/0306-3623(93)90327-t. Gen Pharmacol. 1993. PMID: 8387053

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

16 results

Search Page

Filters